MARKET

STUDIES

BUSINESS

SERVICE

PORTFOLIO

MANAGEMENT

STRATEGY

Helmut Kaiser

Consultancy

Unternehmensberatung

RESEARCH

Investment &

Investor Service,

Change-Management

Technology-Market,

Stockmarkets Worldwide

21. Century Trends

State of Science,

Trends and Waves,

Technologies

Multi-client,

Exclusive,

Political

Business Development,

JV, M+A,

Audits

Summary Regarding China's Growth Markets.

can be ordered now!

Your China Business

Your address in Beijing from 150 $ per month

Your company/repr. from 200 $ per month

We establish your company from 3000 $

Furrther services:

Market research

Consultancy

Legal service

Tax service

Recruitment service

Business service

for more, please click

China Stock-

market Service

We build your portfolio from 50,000 US$

We open your bank account with your address in Beijing

Further services:

Research

Risk studies

Portfolio management

for more, please click

GREEN JOBS

Specialists, Executives, Management

Home

STUDY and BOOK new 2018

Alzheimer 2040

Alzheimer and Alzheimer Business

Alzheimer disease ( AD ) is a special form of dementia that can start as early as 45 years of age, but mostly around age 65. Alzheimer is one of the 60 known different dementia diseases.

By 2040 it is expected that there are worldwide over 290 million people living with

the Alzheimer's disease, in the third stage. Twice as many people do not even know that they are already in a stage of Alzheimer's Disease.

Today it is already a big and fast growing business worldwide and it will have high growth rates to 2040 and a market of over 4560 billion US $. Alzheimer's disease is developing

an industry with many branches, services and products and jobs on different levels.

This study discusses the state of science, applications, companies, research, leading medical institutions, associations, business and industries worldwide and the development

to 2040, by years and total. The study took over one year to complete by interviews

and using scientific materials, publications and company information. Alzheimer's Disease

must not be fate. There are diagnostic methods and prevention, pharmaceuticals and

devices, training and education. There are promising scientific research and developments

in several countries worldwide. The key is the early diagnosis, but alternative methods like Traditional Chinese Medicine can and will also play an important role in an early stage, similar to vitamins and minerals and more.

Part A as hardcover Book 49 Euro + 5 Euro Postage

Part A as e-Book150 Euro

Part A and B as total study      4900 Euro

Worldwide Market for Alzheimer’s Disease (AD) Business 2013-2040

Diagnostic, Prevention, Therapy, Research, Competition

PART A: Alzheimer’s Disease – Background, Diagnosis, Prevention, Therapy, Research

I.Initial Situation

II.Background information

a.Definition of Dementia

b.Definition of Alzheimer’s Disease (AD)

c.ICD-10

d.Epidemiology

e.Stages of AD

i.Pre dementia

ii.Early

iii.       Moderate

iv.Advance

f.Pathophysiology/Disease mechanism

i.Causes

ii.Neuropathology

iii.Genetics

III.Diagnosis

a.Criteria

b.Techniques

i.Imaging

ii.non imaging

iii.biomarkers

iv.others                                   

IV.Prevention

a.Food

b.Supplements

c.Herbal

d.Brain training

e.others

V.Therapy and Patient management

a.Overview

b.Care facilities

c.Nursing homes

d.Specialized institutions

e.Others

VI.Prognosis

VII.Burden of disease

a.Cost

b.Acceptance

c.State of research

B Markets for Alzheimer’s Disease (AD) Worldwide 2012-2040 – Regions, Countries, Prevention, Diagnosis, Therapy

I.Market for Dementia Worldwide

a.Market for Dementia worldwide by regions

b.Market for Dementia worldwide by leading countries

c.Market for Dementia patient care worldwide

II.Market for Alzheimer Worldwide

a.Market for AD worldwide by regions

b.Market for AD worldwide by leading countries

c.Market for AD diagnostics worldwide

d.Market for AD therapy worldwide

e.Market for AD prevention worldwide

f.Market for AD Patient management / care

g.Value Chain

h.Current Market Situation

i.Competition

j.Trends and Developments

k.Research

l.Company Overview

III.Market for Diagnostics

a.Overview of AD Diagnostics

i.Tests

1.Cognitive

2.Neurophysiological

ii.Neuroimaging

1.SPECT

2.PET

3.MRI

iii.Cerebrospinal fluid

iv.Blood tests

1.Biomarkers

2.Others

v.Others

b.Worldwide Markets for AD diagnostics by technologies/segments

c.Worldwide Markets for AD diagnostics by regions

d.Worldwide Markets for AD diagnostics by leading countries

i.USA

ii.Canada

iii.Japan

iv.Germany

e.Developments and Research

IV.Markets for Prevention

a.Overview

i.Risk factors

ii.Protective factors

iii.Supplements

b.Worldwide markets for supplements in Alzheimer’s Disease prevention by segments

i.Vitamins

ii.Medication

iii.Herbal supplements

1.Gingko biloba

2.Curcumma

3.Omega-3 fatty acids

4.Tea

iv.Brain training

v.Others

V.Markets for Therapy

a.Overview of approved products/drugs

b.Worldwide Markets for Alzheimer’s Disease (AD) Medications by substance classes

c.Worldwide markets for Alzheimer Disease medications by products

d.Worldwide Markets for AD therapy by regions

e.Worldwide Markets for AD therapy by leading countries

f.Potential New Drugs/Drug Pipelines Phases I-III

i.Background

1.Phase I

2.Phase II

3.Phase III

VI.Markets for Patient care and management

a.Overview of management and care systems

b.Market for AD patient management worldwide

i.By severity of disease

1.Early

2.Moderate

3.Severe

ii.By institutions

1.Nursing homes

2.At home care/mobile

3.Specialized AD nursing homes

4.Others

iii.By regions

1.USA

2.West Europe

3.East Europe

4.Asia

5.Others

iv.By leading countries

v.Problems associated with patient care/management

vi.Future manegement and care situation

VII.Competition

a.Overview – Competition Structure

b.Leading Pharmaceutical manufacturers

c.Drug Research and Patents

d.Market Share Analysis

e.Leading companies in AD Business by segments

VIII.Research and Developments

a.Field of research

i.Therapy

ii.Diagnostics

iii.Prevention

b.New Technologies

i.Nanotechnology

ii.Others

Pricing of the Study

Part A and B (Total Study)4900 Euro

To order please contact us hku-tuebingen@t-online.de